In today’s Pharma Pulse, the FDA launches its "PreCheck" pilot to speed up domestic factory approvals, while new SELECT trial data shows that semaglutide significantly slashes hospital admission rates ...
Lastly, Insilico Medicine has inked a $120 million deal with Qilu Pharmaceuticals. The company will be using Insilico’s ...
2023 should have been a recovery year for the supply chain, following the major disruptions of 2022, but problems remained with parts shortages and shipping problems. Will 2024 be any better? A group ...
In the past decade, supply chains have become more complex and globalised. With the rise of e-commerce and the 24/7 demand for goods and services, organisations are expected to contend with a more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results